Sign In
to Vote &
Create Storyboards.
 
(Cactus Communications) Vaccines are critical tools for fighting COVID-19, and new vaccines will expand overall vaccine availability. In an article recently published in Chinese Medical Journal, a research team use phase 1 and 2 clinical trial data to show that a vaccine called KCONVAC, which contains an inactivated virus, is safe and can stimulate antibody production. These findings support the initiation of a phase 3 trial to confirm that the vaccine is safe and effective.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard